AWM Investment Company Inc. Invests $9.84 Million in ASP Isotopes Inc. $ASPI

Key Points

• AWM Investment Company acquired 1.58 million ASP Isotopes shares worth approximately $9.84 million, giving it about a 1.03% stake. Institutional investors collectively own 16.80% of the company.
• ASP Isotopes reported quarterly revenue of $5.12 million, exceeding estimates of $4.47 million, but its adjusted loss of $0.28 per share was wider than the expected $0.17 loss. The company posted a negative net margin of 427.98%.
• The stock opened at $4.00, near its one-year low of $3.51 and well below its one-year high of $14.49. Analyst sentiment remains mixed, with a consensus “Hold” rating and a $13.00 price target, while insiders have sold $2.05 million in shares over the past three months.

AWM Investment Company Inc. acquired a new stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,581,490 shares of the company's stock, valued at approximately $9,837,000. AWM Investment Company Inc. owned approximately 1.03% of ASP Isotopes as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. State of Wyoming bought a new stake in ASP Isotopes during the first quarter worth approximately $29,000. Quantbot Technologies LP bought a new stake in shares of ASP Isotopes during the 3rd quarter worth $34,000. BNP Paribas Financial Markets boosted its holdings in shares of ASP Isotopes by 84.9% during the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company's stock worth $41,000 after buying an additional 2,548 shares during the period. Stephens Inc. AR acquired a new position in ASP Isotopes in the 1st quarter valued at $44,000. Finally, Broadhurst Jeffrey B acquired a new position in ASP Isotopes in the 1st quarter valued at $44,000. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Stock Performance

ASPI opened at $4.00 on Wednesday. The stock's 50 day simple moving average is $4.84 and its 200-day simple moving average is $5.28. The company has a current ratio of 3.87, a quick ratio of 3.85 and a debt-to-equity ratio of 0.76. The stock has a market cap of $613.24 million, a PE ratio of -3.03 and a beta of 3.61. ASP Isotopes Inc. has a 1 year low of $3.51 and a 1 year high of $14.49.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last announced its quarterly earnings results on Friday, August 14th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.11). ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%. The business had revenue of $5.12 million during the quarter, compared to the consensus estimate of $4.47 million.

Insider Buying and Selling at ASP Isotopes

In other ASP Isotopes news, Director Todd Wider sold 50,000 shares of the stock in a transaction on Monday, June 29th. The stock was sold at an average price of $6.25, for a total transaction of $312,500.00. Following the completion of the transaction, the director directly owned 722,247 shares in the company, valued at $4,514,043.75. This represents a 6.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Heather Kiessling sold 23,124 shares of ASP Isotopes stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $6.28, for a total transaction of $145,218.72. Following the transaction, the chief financial officer directly owned 1,526,252 shares of the company's stock, valued at $9,584,862.56. This represents a 1.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 279,079 shares of company stock worth $2,049,208 over the last three months. 14.40% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

ASPI has been the subject of a number of research analyst reports. Wall Street Zen raised shares of ASP Isotopes from a "strong sell" rating to a "sell" rating in a research report on Saturday. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of ASP Isotopes in a research report on Wednesday, June 24th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $13.00.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

Want to see what other hedge funds are holding ASPI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ASP Isotopes Inc. (NASDAQ:ASPI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source